Severe pancytopenia following etanercept administration in rheumatoid arthritis.
Virginia
V
Martínez Santana
María
M
Izquierdo Navarro
Miguel Ángel
MÁ
Calleja Hernández
Teresa
T
Sánchez Sánchez
María
M
Sainz Gil
D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D000068800:Etanercept; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D010198:Pancytopenia / Q000139:chemically induced* / Q000473:pathology; D018124:Receptors, Tumor Necrosis Factor
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept